Awarded recognition by The Endocrine Society for outstanding research in the field of Reproductive Endocrinology

Board Certified in Reproductive Endocrinology and Infertility and Obstetrics and Gynecology

Society for Reproductive Endocrinology and Infertility

American Society for Reproductive Medicine

Amercian College of Obstetrics and Gynecology

American Medical Association

Zinger M. “Physiology of menstruation” in Modern Management of Abnormal Uterine Bleeding. O’Donovan PJ, Miller CE (eds). London, Informa Healthcare, 2008.
Zinger M. “Epidemiology of abnormal uterine bleeding” in Modern Management of Abnormal Uterine Bleeding. O’Donovan PJ, Miller CE (eds). London, Informa Healthcare, 2008.
Miller CE, Zinger M. “Endoscopic treatment for infertility.” Perioperative Nursing Clinics 2006; 1(4): 337-44.
Zinger M, Liu JH, Husseinzadeh N, Thomas MA. “Successful surrogate pregnancy following ovarian transposition, pelvic irradiation, and hysterectomy.” The Journal of Reproductive Medicine, 2004; 49(7): 573-4.
Zinger M, Liu JH. “Diagnostic tests for evaluation of ovarian function.” in Diagnosis and Management of Ovarian Disorders, 2d ed., Altcheck A, Deligdisch L, Kase N (eds). San Diego, Academic Press, 2003.
Zinger M, McFarland M, Ben-Jonathan N. “Prolactin expression and secretion by human breast glandular and adipose tissue explants” Journal of Clinical Endocrinology and Metabolism, 2003; 88: 689-696.
Ben-Jonathan N, Liby K, McFarland M, Zinger M. “Prolactin as an autocrine/paracrine growth factor in human cancer” Trends in Endocrinology and Metaolism, 2002 Aug; 13(6): 245-50.
Rebar RW, Hodgen GD, Zinger M. “The normal menstrual cycle and the control of ovulation.” in Principles and Practice of Endocrinology and Metabolism, 3d ed., Becker KL (ed). New York, Lippincott Williams & Wilkins, 2001, chapt. 95, pp 935-47.
Zinger M, Thomas MA. “Using the levonorgestrel intra-uterine system.” Contemporary OB/GYN 2001; 46: 35-48.
Zinger M, Rosenfeld D. “Failed treatment of abdominal pregnancy with methotrexate: a case report.” The Journal of Reproductive Medicine 2001; 46:
392-4.
Zinger M, Liu JH. “Therapeutic applications of micronized progesterone.” Today’s Therapeutic Trends 2000; 18: 165-79.
Hershlag A, Zinger M, Lesser M, Scholl G, Bjornson L. “Is chemiluminescence immunoassay (CIA) an appropriate substitution for radio-immunoassay (RIA) in monitoring estradiol levels?” Fertility & Sterility 2000; 73: 1174-8.
Lindheim SR, Ditkoff EC, Sauer MV, Zinger M. “Differences in ovarian stimulation among older and younger women with a diminished gonadal reserve.” Journal of Assisted Reproduction and Genetics 1997; 14: 235-7.
Lindheim SR, Vidali A, Ditkoff E, Sauer MV, Zinger M. “Poor responders to ovarian hyperstimulation may benefit from an attempt at natural-cycle oocyte retrieval.” Journal of Assisted Reproduction and Genetics 1997; 14: 174-6.
Lindheim SR, Barad DH, Zinger M, Witt B, Amin H, Cohen B, Fisch H, Barg P. “Abnormal sperm morphology is highly predictive of pregnancy outcome during controlled ovarian hyperstimulation and intrauterine insemination.” Journal of Assisted Reproduction and Genetics 1996; 13: 569-72.
Abstracts
Zinger M, Wrona DA, Desanti R, Miller CE. “Movement of intrauterine air bubble during embryo transfer (ET) catheter withdrawal is not a prognostic indicator.” Presented at The 60th Annual Meeting of the American Society for Reproductive Medicine, Philadelphia, Pennsylvania, October 2004, abstract O-156.
Zinger M, McFarland M, Ben-Jonathan N. “Prolactin expression and secretion by human breast glandular and adipose tissue explants” presented at The 84th Annual Meeting of The Endocrine Society, San Francisco, California, June 2002, abstract OR31-4.
Zinger M, Liu JH, Husseinzadeh N, Thomas MA. “Successful surrogate pregnancy following ovarian transposition, pelvic irradiation, and hysterectomy.” presented at The 49th Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, California, March 2002, abstract # 803.
Zinger M, Thomas MA, Lin J, Robins JC, Liu JH. “Estrogen priming after gonadotropin releasing hormone agonist (GnRH-a) suppression does not augment ovarian response to gonadotropin stimulation.” presented at The 49th Annual Meeting of the Society for Gynecologic Investigation, Los Angeles, California, March 2002, abstract # 832.
Zinger M, Thomas MA, Liu JH. “Vaginal sildenafil improves endometrium in Asherman's Syndrome.” presented at The 57th Annual Meeting of the American Society for Reproductive Medicine, Orlando, Florida, October, 2001,
abstract P-430.
Zinger M, Weingand K, Robins JC, Petty S, Sagel P, Thomas MA. “Symptomatic relief of primary dysmenorrhea with transdermal heat.” presented at The 48th Annual Meeting of the Society for Gynecologic Investigation, Toronto, Canada, March 2001, abstract # 387.
Hershlag A, Zinger M, Lesser M, Scholl G, Bjornson L. “Is chemiluminescence immunoassay (CIA) an appropriate substitution for radio-immunoassay (RIA) in monitoring estradiol levels?” presented at the 54th Annual Meeting of the American Society for Reproductive Medicine, October 1998, abstract P-861.
Barg P, Lindheim SR, Zinger M, Spitzer C, Amin H, Cohen BL, Witt B, Fisch H, Barad DH. “Predictive value of single versus multiple morphological assessment of spermatozoa after in vitro fertilization.” Presented at the 51st Annual Meeting Meeting of the American Society for Reproductive Medicine, San Antonio, Texas, November 1995, abstract P-161.
Barad DH, Lindheim SR, Zinger M, Witt B, Cohen BL, Amin H, Fisch H, Barg PE. “Sperm morphology predicts pregnancy more accurately after intrauterine insemination than after in vitro fertilization.” Presented at the 51st Annual Meeting Meeting of the American Society for Reproductive Medicine, San Antonio, Texas, November 1995, abstract P-275.